Sintesi Research

Sintesi Research

Milan, Italy· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Sintesi Research is a private, Milan-based Contract Research Organization (CRO) established in 2006. It provides clinical research services to biotech and pharma clients, emphasizing quality, attention to detail, and on-time, on-budget project execution. The company leverages expertise in drug delivery and small molecules to support client programs, positioning itself as a trusted partner in the drug development process. Its business model is service-based, generating revenue through contracted research work.

Drug DeliverySmall Molecules

Technology Platform

Integrated CRO services specializing in drug delivery technologies and small molecule pharmaceutical development, including formulation, analytical development, and clinical research operations.

Opportunities

Growing demand for specialized drug delivery expertise from biotech firms lacking internal capabilities.
The sustained importance of small molecule therapeutics and the trend towards outsourcing in pharma R&D create a stable service market.
Its location in Italy provides access to the European biopharma ecosystem.

Risk Factors

Revenue dependency on a fluctuating portfolio of client projects and the financial health of the biotech sector.
High competition from both large global CROs and niche specialists.
Operational risks related to maintaining quality and on-time delivery across all projects.

Competitive Landscape

Sintesi competes in the fragmented global CRO market, facing large, full-service firms (e.g., IQVIA, ICON) and many smaller, specialized service providers. Its differentiation is based on deep expertise in drug delivery and small molecules, a quality-focused client approach, and its European base. Competition is based on scientific reputation, cost, and service reliability.